Duloxetine antidepressant recalled over presence of toxic chemical

Thousands of bottles of nan antidepressant duloxetine, which is sold nether nan marque sanction Cymbalta, person been recalled owed to nan beingness of a toxic chemical, according to a notice from nan Food and Drug Administration. 

The October 10 callback is owed to nan beingness of N-nitroso-duloxetine, a chemic that is toxic if swallowed and is suspected of causing cancer, according to nan National Library of Medicine. The FDA classified nan callback arsenic Class II, which intends that nan supplier could origin "temporary aliases medically reversible adverse wellness consequences."

The medication, manufactured by Towa Pharmaceutical Europe, was distributed nationally passim nan U.S., according to nan callback notice.

Towa and nan FDA didn't instantly respond to requests for comment.

Duloxetine recall

The callback covers 7,107 bottles of duloxetine, nan FDA said. The bottles see 500 delayed-release 20mg capsules. The batch number is 220128, pinch an expiration day of 12/2024.

Duloxetine, a selective serotonin and norepinephrine reuptake inhibitor (SSRI), is prescribed for worry and depression, and tin besides beryllium utilized to dainty nervus symptom for group pinch diabetes, nan Mayo Clinic notes. It's besides utilized for group pinch fibromyalgia and chronic symptom related to bones and muscles, it adds.

In:
• Product Recall